Doxazosin-d8 (hydrochloride) – 500 µg

Brand:
Cayman
CAS:
1219803-95-8
Storage:
-20
UN-No:
Non-Hazardous - /

Doxazosin-d8 is intended for use as an internal standard for the quantification of doxazosin (Item No. 18633) by GC- or LC-MS. Doxazosin is a non-selective antagonist of α1-adrenergic receptors (α1-ARs; Kis = 3.16, 1, and 3.98 nM for α1A-, α1B-, and α1D-ARs, respectively).{18268} It inhibits norepinephrine-induced contractions in isolated rat aortic rings and human prostate strips with pA2 values of 8.8 and 8.2, respectively. Doxazosin inhibits phenylephrine-induced increases in blood pressure and prostatic pressure in anesthetized dogs (pA2 = 7.5 for both). Formulations containing doxazosin have been used in the treatment of benign prostatic hyperplasia and hypertension.  

 

Available on backorder

SKU: 30979 - 500 µg Category:

Description

An internal standard for the quantification of doxazosin by GC- or LC-MS


Formal name: [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl-2,2,3,3,5,5,6,6-d8](2,3-dihydro-1,4-benzodioxin-2-yl)-methanone, monohydrochloride

Synonyms: 

Molecular weight: 496

CAS: 1219803-95-8

Purity: ≥99% deuterated forms (d1-d8)

Formulation: A solid